Yves Van Laethem
- Infectious Diseases top 2%
- Epidemiology top 5%
- Molecular Medicine top 1%
- Neurology top 5%
- Molecular Biology
- Co-authors
- Françoise Van BambekePaul M. TulkensJean KlášterskýPatrice CourvalinY. GlupczynskiM. Roussel‐DelvallezJohan Van EldereF. Jacobs
- Topics
- Antibiotics Pharmacokinetics and Efficacy (11 papers)Antibiotic Resistance in Bacteria (10 papers)Pneumonia and Respiratory Infections (9 papers)
In The Last Decade
Yves Van Laethem
48 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Infectious Diseases 675
- Epidemiology 512
- Molecular Medicine 490
- Neurology 346
- Molecular Biology 334
Countries citing papers authored by Yves Van Laethem
This map shows the geographic impact of Yves Van Laethem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves Van Laethem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves Van Laethem more than expected).
Fields of papers citing papers by Yves Van Laethem
This network shows the impact of papers produced by Yves Van Laethem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves Van Laethem. The network helps show where Yves Van Laethem may publish in the future.
Co-authorship network of co-authors of Yves Van Laethem
This figure shows the co-authorship network connecting the top 25 collaborators of Yves Van Laethem. A scholar is included among the top collaborators of Yves Van Laethem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yves Van Laethem. Yves Van Laethem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019breakdown → | 561 |
| 3 | 2 | |
| 4 | 8 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 29 | |
| 8 | Improvement of routine diagnosis of intestinal parasites with multiple sampling and SAF-fixative in the triple-faeces-test. | 15 |
| 9 | 2 | |
| 10 | 7 | |
| 11 | 164 | |
| 12 | 12 | |
| 13 | Salvage anti HIV triple therapy with Foscarnet in combination with Nelfinavir and Nevirapine in heavily pretreated patients | 1 |
| 14 | 18 | |
| 15 | 9 | |
| 16 | 77 | |
| 17 | 36 | |
| 18 | 1 | |
| 19 | 6 | |
| 20 | 2 |
About Yves Van Laethem
Yves Van Laethem is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 50 papers that have together received 2.1k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Resistance in Bacteria (10 papers) and Pneumonia and Respiratory Infections (9 papers). The work is most often cited by research in Molecular Medicine (490 citations), Applied Microbiology and Biotechnology (110 citations) and Infectious Diseases (675 citations). Yves Van Laethem has collaborated with scholars based in Belgium, France and Czechia. Frequent co-authors include Françoise Van Bambeke, Paul M. Tulkens, Jean Klášterský, Patrice Courvalin, Y. Glupczynski, M. Roussel‐Delvallez, Johan Van Eldere, F. Jacobs, Patrick Plésiat and Patrick Lebecque. Their work appears in journals such as Annals of Internal Medicine, Cancer and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.